Latest Shareholder Approval News

West Cobar Metals has raised $1.5 million through a discounted share placement to fund key exploration and testwork at its critical minerals projects, signalling renewed momentum in its development pipeline.

Eastern Metals is progressing its acquisition of Raptor Resources and has agreed to sell its Browns Reef Project, while planning a $4-5 million capital raise pending shareholder approval.

AMA Group Limited reported a robust FY25 with a 38.4% rise in normalized EBITDA and significant net debt reduction, setting a confident tone for FY26. Operational improvements across key divisions underpin the company’s optimistic outlook.

Skin Elements Limited reports successful completion of key product evaluations and secures $2.5 million placement to fuel growth and commercialisation in 2026.

Metal Bank Limited is advancing its Western Australia gold strategy with significant resource development at Livingstone and a binding agreement to acquire Hastings Technology Metals’ WA gold assets, while also progressing critical minerals projects in Queensland and Saudi Arabia.

Argent BioPharma has secured a transformative acquisition of AusCann’s core assets, bolstering its drug delivery technology and manufacturing capabilities ahead of a planned U.S. listing. The company also reported key clinical milestones and refinancing moves in its September 2025 quarterly update.

Lodestar Minerals reports promising gold drilling results at Ned’s Creek, advances exploration in Chile, and announces a strategic acquisition of a US rare earth project.

Alice Queen Limited has reported significant progress at its Viani Fiji Project, extending high-grade gold mineralisation over a 5km strike. The company also registered a mining lease application for its Horn Island Project and raised $1 million via convertible notes to fund ongoing exploration.

Infinity Mining’s latest quarterly report reveals promising high-grade gold assays at its Sir Walter Scott prospect in NSW and new exploration targets in Victoria, signaling renewed momentum in its Eastern Australian portfolio.

InhaleRx has secured FDA alignment and ethics approvals to progress clinical trials for its inhaled therapies targeting breakthrough cancer pain and panic disorder, with patient dosing set to begin soon.

Australian Oil Company Limited reports stronger gas production in California’s Sacramento Basin and an $800,000 capital raise to advance new ventures and operational upgrades.

InFocus Group Holdings has launched two new strategic units targeting digital assets and iGaming, backed by a significant loan and guided by a newly formed advisory board featuring industry veterans.